| Canis lupus familiaris |
MDCK |
Ratio |
1.13 |
None |
10.1016/j.bmcl.2015.04.074 |
| Homo sapiens |
CDGSH iron-sulfur domain-containing protein 1 |
IC50 |
nan |
None |
10.1016/j.bmcl.2016.09.009 |
| Homo sapiens |
CDGSH iron-sulfur domain-containing protein 1 |
Ki |
nan |
None |
10.1016/j.bmcl.2016.09.009 |
| Homo sapiens |
Cytochrome P450 |
Drug metabolism |
3.11 |
% |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Glutamate [NMDA] receptor |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.7b01199 |
| Homo sapiens |
HEK293 |
EC50 |
1300.0 |
nM |
10.1016/j.bmcl.2004.06.035 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
0.4 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
14.12 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
KCNQ4/KCNQ5 |
EC2 |
nan |
None |
10.1021/acsmedchemlett.9b00097 |
| Homo sapiens |
Liver microsome |
CL |
8.0 |
mL.min-1.kg-1 |
10.1016/j.bmcl.2015.04.074 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-1 |
Km |
460000.0 |
nM |
10.1016/j.pharmthera.2004.10.013 |
| Homo sapiens |
UDP-glucuronosyltransferase 1A4 |
Km |
322000.0 |
nM |
10.1016/j.pharmthera.2004.10.013 |
| Homo sapiens |
UDP-glucuronosyltransferase 1A4 |
Km |
322000.0 |
nM |
10.1021/jm020397c |
| Homo sapiens |
UDP-glucuronosyltransferases (UGTs) |
Drug metabolism |
11.41 |
% |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel KCNQ3/KCNQ5 |
EC2 |
0.34 |
uM |
10.1021/acsmedchemlett.9b00097 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
Activity |
-26.81 |
mV |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
Activity |
0.027 |
None |
10.1021/acs.jmedchem.2c00911 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
Activity |
0.32 |
uM |
10.1016/j.bmcl.2018.09.036 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
Activity |
nan |
None |
10.1016/j.ejmech.2011.01.010 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c00911 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
delta(V1/2) |
10.0 |
mV |
10.1021/acs.jmedchem.2c00911 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
EC2 |
0.33 |
uM |
10.1021/acsmedchemlett.9b00097 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
EC50 |
430.0 |
nM |
10.1016/j.ejmech.2011.01.010 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
EC50 |
1720.0 |
nM |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
EC50 |
2500.0 |
nM |
10.1021/acs.jmedchem.2c00911 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
EC50 |
4380.0 |
nM |
10.1016/j.bmcl.2019.08.007 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
EC50 |
11200.0 |
nM |
10.1021/acs.jmedchem.2c00911 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
Emax |
99.0 |
% |
10.1016/j.bmcl.2019.08.007 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
FC |
0.99 |
None |
10.1021/acs.jmedchem.2c00911 |
| Homo sapiens |
Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) |
Inhibition |
100.0 |
% |
10.1016/j.ejmech.2022.114413 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.1 |
Activity |
-8.03 |
mV |
10.1021/acs.jmedchem.0c02252 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.1 |
Activity |
1.01 |
None |
10.1021/acs.jmedchem.0c02252 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.1 |
Activity |
nan |
None |
10.1016/j.ejmech.2011.01.010 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.1 |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
Activity |
-25.37 |
mV |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
Activity |
40.0 |
mV |
10.1016/j.bmcl.2018.04.040 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
Activity |
40.21 |
% |
10.1016/j.bmcl.2018.04.040 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
Activity |
40.21 |
% |
10.1016/j.bmcl.2018.05.019 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
EC50 |
150.0 |
nM |
10.1021/jm060989l |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
EC50 |
350.0 |
nM |
10.1016/j.bmcl.2018.04.040 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
EC50 |
350.0 |
nM |
10.1016/j.bmcl.2018.05.019 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
EC50 |
930.0 |
nM |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
EC50 |
4210.0 |
nM |
10.1016/j.bmcl.2022.128841 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
Efficacy |
210.0 |
% |
10.1016/j.bmcl.2018.04.040 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
Emax |
54.4 |
mV |
10.1016/j.bmcl.2022.128841 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
Ratio |
2.0 |
None |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
Ratio |
2.12 |
None |
10.1016/j.bmcl.2018.04.040 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
Ratio |
2.12 |
None |
10.1016/j.bmcl.2018.05.019 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
Ratio |
6.0 |
None |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
V1/2 |
-34.3 |
mV |
10.1016/j.bmcl.2022.128841 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
V1/2 |
-24.4 |
mV |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.2 |
V1/2 |
40.0 |
mV |
10.1016/j.bmcl.2018.05.019 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.3 |
Activity |
-39.88 |
mV |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.3 |
EC50 |
3900.0 |
nM |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.4 |
Activity |
-34.09 |
mV |
10.1021/acs.jmedchem.0c02252 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.4 |
Activity |
-15.19 |
mV |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.4 |
Activity |
2.85 |
None |
10.1021/acs.jmedchem.0c02252 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.4 |
Activity |
20.0 |
mV |
10.1021/acsmedchemlett.8b00315 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.4 |
EC2 |
nan |
None |
10.1021/acsmedchemlett.9b00097 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.4 |
EC50 |
1980.0 |
nM |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.4 |
EC50 |
5900.0 |
nM |
10.1021/acsmedchemlett.8b00315 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.5 |
Activity |
-21.95 |
mV |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.5 |
Activity |
0.09 |
mV |
10.1021/acs.jmedchem.0c02252 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.5 |
Activity |
3.04 |
None |
10.1021/acs.jmedchem.0c02252 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.5 |
EC50 |
800.0 |
nM |
10.1021/acs.jmedchem.9b00796 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv7.5 |
EC50 |
3450.0 |
nM |
10.1021/acsmedchemlett.8b00315 |
| Mus musculus |
Brain |
EC50 |
2230.0 |
nM |
10.1021/acs.jmedchem.0c02252 |
| Mus musculus |
Brain |
EC50 |
27320.0 |
nM |
10.1021/acs.jmedchem.0c02252 |
| Mus musculus |
Mus musculus |
Activity |
6.9 |
None |
10.1021/acs.jmedchem.2c00911 |
| Mus musculus |
Mus musculus |
Activity |
15.0 |
% |
10.1016/j.bmcl.2018.05.019 |
| Mus musculus |
Mus musculus |
Activity |
50.0 |
% |
10.1021/acs.jmedchem.0c02252 |
| Mus musculus |
Mus musculus |
Activity |
60.0 |
% |
10.1021/acs.jmedchem.0c02252 |
| Mus musculus |
Mus musculus |
Activity |
62.5 |
% |
10.1021/acs.jmedchem.0c02252 |
| Mus musculus |
Mus musculus |
Activity |
87.5 |
% |
10.1021/acs.jmedchem.0c02252 |
| Mus musculus |
Mus musculus |
EC50 |
20040.0 |
nM |
10.1021/acs.jmedchem.0c02252 |
| Mus musculus |
Mus musculus |
EC50 |
141330.0 |
nM |
10.1021/acs.jmedchem.0c02252 |
| Mus musculus |
Mus musculus |
ED50 |
15.0 |
mg.kg-1 |
10.1021/acs.jnatprod.5b00766 |
| Mus musculus |
Mus musculus |
ED50 |
38.6 |
mg.kg-1 |
10.1021/acs.jmedchem.0c02252 |
| Mus musculus |
Mus musculus |
ED50 |
56.0 |
mg.kg-1 |
10.1021/acs.jmedchem.0c02252 |
| Mus musculus |
Mus musculus |
ED50 |
65.9 |
mg.kg-1 |
10.1021/acs.jmedchem.0c02252 |
| Mus musculus |
Mus musculus |
ED50 |
102.5 |
mg.kg-1 |
10.1021/acs.jmedchem.0c02252 |
| Mus musculus |
Mus musculus |
TIME |
0.2893 |
hr |
10.1021/acs.jmedchem.2c00911 |
| Mus musculus |
Voltage-gated potassium channel subunit Kv7.2 |
EC50 |
1300.0 |
nM |
10.1016/j.bmcl.2004.01.069 |
| Mus musculus |
Voltage-gated potassium channel subunit Kv7.2 |
EC50 |
1300.0 |
nM |
10.1016/j.bmcl.2004.10.065 |
| Mus musculus |
Voltage-gated potassium channel subunit Kv7.2 |
EC50 |
1300.0 |
nM |
10.1016/j.bmcl.2013.08.092 |
| Mus musculus |
Voltage-gated potassium channel subunit Kv7.2 |
E/Eref |
1.6 |
None |
10.1016/j.bmcl.2004.01.069 |
| Mus musculus |
Voltage-gated potassium channel subunit Kv7.2 |
E/Eref |
1.6 |
None |
10.1016/j.bmcl.2004.10.065 |
| Mus musculus |
Voltage-gated potassium channel subunit Kv7.2 |
Increase |
269.0 |
% |
10.1016/j.bmcl.2004.01.073 |
| Mus musculus |
Voltage-gated potassium channel subunit Kv7.2 |
Ratio |
1.6 |
None |
10.1016/j.bmcl.2013.08.092 |
| Rattus norvegicus |
PC-12 |
Activity |
64.0 |
% |
10.1021/acs.jmedchem.7b01199 |
| Rattus norvegicus |
PC-12 |
Activity |
73.92 |
% |
10.1021/acs.jmedchem.7b01199 |
| Rattus norvegicus |
PC-12 |
Activity |
nan |
None |
10.1021/acs.jmedchem.7b01199 |
| Rattus norvegicus |
PC-12 |
FC |
2.0 |
None |
10.1021/acs.jmedchem.7b01199 |
| Rattus norvegicus |
Potassium voltage-gated channel subfamily KQT member 2/member 3 |
Activity |
-34.32 |
mV |
10.1021/acs.jmedchem.0c02252 |
| Rattus norvegicus |
Potassium voltage-gated channel subfamily KQT member 2/member 3 |
Activity |
1.97 |
None |
10.1021/acs.jmedchem.0c02252 |
| Rattus norvegicus |
Potassium voltage-gated channel subfamily KQT member 2/member 3 |
EC50 |
4150.0 |
nM |
10.1021/acs.jmedchem.0c02252 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.0 |
% |
10.1016/j.bmcl.2018.05.019 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.0 |
% |
10.1021/jm901497b |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
49.0 |
% |
10.1021/jm901497b |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1021/jm901497b |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
6.6 |
mg.kg-1 |
10.1021/jm060989l |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
40.0 |
mg.kg-1 |
10.1021/jm060989l |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
47.6 |
mg.kg-1 |
10.1021/jm060989l |
| Rattus norvegicus |
Rattus norvegicus |
MED |
10.0 |
mg kg-1 |
10.1021/jm060989l |
| Rattus norvegicus |
Voltage-gated potassium channel subunit Kv7.2 |
Activity |
-33.2 |
mV |
10.1021/acs.jmedchem.0c02252 |
| Rattus norvegicus |
Voltage-gated potassium channel subunit Kv7.2 |
Activity |
1.79 |
None |
10.1021/acs.jmedchem.0c02252 |
| Rattus norvegicus |
Voltage-gated potassium channel subunit Kv7.2 |
Activity |
20.0 |
mV |
10.1021/acsmedchemlett.8b00315 |
| Rattus norvegicus |
Voltage-gated potassium channel subunit Kv7.2 |
EC50 |
2040.0 |
nM |
10.1021/acs.jmedchem.0c02252 |
| Rattus norvegicus |
Voltage-gated potassium channel subunit Kv7.2 |
EC50 |
2170.0 |
nM |
10.1021/acsmedchemlett.8b00315 |
| Rattus norvegicus |
Voltage-gated potassium channel subunit Kv7.2 |
Ratio |
1.6 |
None |
10.1021/acsmedchemlett.8b00315 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
7.961 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1746 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.12 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
1.55 |
% |
10.21203/rs.3.rs-23951/v1 |
| None |
ADMET |
Activity |
40.0 |
% |
10.1021/acs.jmedchem.2c00911 |
| None |
ADMET |
Activity |
62.5 |
% |
10.1021/acs.jmedchem.0c02252 |
| None |
ADMET |
Activity |
100.0 |
% |
10.1021/acs.jmedchem.0c02252 |
| None |
ADMET |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c02252 |
| None |
ADMET |
Cp |
40.85 |
uM |
10.1021/acs.jmedchem.0c02252 |
| None |
ADMET |
Cp |
134.89 |
uM |
10.1021/acs.jmedchem.0c02252 |
| None |
ADMET |
Cp |
202.2 |
ng/mg |
10.1021/acs.jmedchem.2c00911 |
| None |
ADMET |
Ct |
8.29 |
uM |
10.1021/acs.jmedchem.0c02252 |
| None |
ADMET |
Ct |
41.62 |
uM |
10.1021/acs.jmedchem.0c02252 |
| None |
ADMET |
Ct |
469.2 |
ng/mg |
10.1021/acs.jmedchem.2c00911 |
| None |
ADMET |
Drug metabolism |
4.7 |
% |
10.1021/acs.jmedchem.2c00911 |
| None |
ADMET |
Drug metabolism |
17.4 |
% |
10.1021/acs.jmedchem.2c00911 |
| None |
ADMET |
IC50 |
213000.0 |
nM |
10.1016/j.bmcl.2015.04.074 |
| None |
ADMET |
permeability |
34.2 |
ucm/s |
10.1016/j.bmcl.2015.04.074 |
| None |
ADMET |
PPB |
79.92 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
PPB |
86.05 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Ratio |
0.11 |
None |
10.1021/acs.jmedchem.0c02252 |
| None |
ADMET |
Ratio |
0.19 |
None |
10.1021/acs.jmedchem.0c02252 |
| None |
ADMET |
Ratio |
2.3 |
None |
10.1021/acs.jmedchem.2c00911 |
| None |
ADMET |
Ratio |
12.3 |
None |
10.1021/acs.jmedchem.0c02252 |
| None |
ADMET |
Ratio TD50/ED50 |
4.9 |
None |
10.1021/acs.jmedchem.0c02252 |
| None |
ADMET |
T1/2 |
2.4 |
hr |
10.1021/acs.jmedchem.2c00911 |
| None |
ADMET |
T1/2 |
6.0 |
hr |
10.1021/acs.jmedchem.9b00796 |
| None |
ADMET |
T1/2 |
16.17 |
hr |
10.1021/acsmedchemlett.9b00097 |
| None |
ADMET |
TD50 |
187.7 |
mg kg-1 |
10.1021/acs.jmedchem.0c02252 |
| None |
ADMET |
TI |
1.6 |
None |
10.1021/jm060989l |
| None |
ADMET |
TI |
4.0 |
None |
10.1021/jm060989l |
| None |
NON-PROTEIN TARGET |
Potency |
5304.5 |
nM |
None |
| None |
No relevant target |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b00796 |
| None |
No relevant target |
Drug degradation |
5.0 |
% |
10.1021/acs.jmedchem.9b00796 |
| None |
No relevant target |
Drug degradation |
9.65 |
% |
10.1021/acs.jmedchem.9b00796 |
| None |
No relevant target |
Drug degradation |
25.16 |
% |
10.1021/acs.jmedchem.9b00796 |
| None |
No relevant target |
Drug degradation |
43.5 |
% |
10.1021/acs.jmedchem.9b00796 |
| None |
No relevant target |
Drug degradation |
47.33 |
% |
10.1021/acs.jmedchem.9b00796 |
| None |
No relevant target |
Drug metabolism |
nan |
None |
10.1021/acs.jmedchem.9b00796 |
| None |
No relevant target |
LogP |
3.08 |
None |
10.1021/acs.jmedchem.2c00911 |
| None |
No relevant target |
LogP |
3.08 |
None |
10.1021/acs.jmedchem.9b00796 |
| None |
No relevant target |
Retention_time |
5.98 |
min |
10.1021/acs.jmedchem.9b00796 |
| None |
No relevant target |
Retention_time |
14.39 |
min |
10.1021/acs.jmedchem.9b00796 |
| None |
Unchecked |
Activity |
-46.83 |
mV |
10.1021/acs.jmedchem.0c02252 |
| None |
Unchecked |
Activity |
2.46 |
None |
10.1021/acs.jmedchem.0c02252 |
| None |
Unchecked |
Activity |
30.0 |
uM |
10.1016/j.bmcl.2018.09.036 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.7b01199 |
| None |
Unchecked |
Drug metabolism |
3.41 |
% |
10.1021/acs.jmedchem.9b00796 |
| None |
Unchecked |
EC50 |
1000.0 |
nM |
10.1021/jm060989l |
| None |
Unchecked |
Emax |
1.11 |
mV |
10.1016/j.bmcl.2022.128841 |
| None |
Unchecked |
Selectivity Index |
nan |
None |
10.1021/acsmedchemlett.9b00097 |
| None |
Unchecked |
V1/2 |
4.2 |
mV |
10.1016/j.bmcl.2022.128841 |